Work

Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110554

Authors: John C. Reneau, Steven R. Hwang, Carlos A. Murga-Zamalloa, Joseph J. Buggy, James W. Janc, Ryan A. Wilcox

Institutions: University of Michigan, Mayo Clinic, U-M Rogel Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980517276

Cites:

Cited by:

Related to: 10